NEU neuren pharmaceuticals limited

Ann: Appendix 4E and 2019 full year accounts, page-5

  1. 7,028 Posts.
    lightbulb Created with Sketch. 757
    It looks like I owe Little T an apology over the need to submit a substantial holder notification.

    I received this, this morning.

    " Thank you for your questions. You’re right that Neuren is subject to ASX Listing Rules, including continuous disclosure, but filing substantial holding notices is an obligation on shareholders not the company and it is governed by Australian law not the Listing Rules. ASX releases them under a company ticker when it receives them from a shareholder. In our case, the part of Australian law that requires shareholders to file them does not apply because we are incorporated in New Zealand.


    FYI, we just released our annual accounts, which in the additional annual information have share details including the current top 20 holders.

    Kind regards, Jon "
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.